Pages that link to "Q42115042"

The following pages link to Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons (Q42115042):

Displaying 31 items.

• Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage (Q21135530) (← links)
• Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells (Q28242307) (← links)
• Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements (Q30354666) (← links)
• Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines (Q30428210) (← links)
• Cloning and characterization of cDNAs encoding four different canine immunoglobulin gamma chains (Q30689316) (← links)
• The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination (Q33943143) (← links)
• DeltaPhage--a novel helper phage for high-valence pIX phagemid display (Q34249101) (← links)
• Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering (Q34984713) (← links)
• Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus (Q35548228) (← links)
• Human antibody effector function (Q35695770) (← links)
• One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge (Q35774772) (← links)
• Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation (Q36156532) (← links)
• Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis (Q36817674) (← links)
• Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface (Q40444495) (← links)
• The influence of the hinge region length in binding of human IgG to human Fcgamma receptors (Q40998108) (← links)
• Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells (Q41047545) (← links)
• The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded (Q41544983) (← links)
• Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis (Q41863626) (← links)
• Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge (Q45094108) (← links)
• Amino acid differences in the n-terminus of CH2 influence the relative abilities of IgG2 AND IgG3 to activate complement (Q46103121) (← links)
• Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52. (Q47864888) (← links)
• Monoclonal antibodies produced by muscle after plasmid injection and electroporation (Q47986812) (← links)
• A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells. (Q53645990) (← links)
• Structural requirements for incorporation of J chain into human IgM and IgA. (Q55033512) (← links)
• Lysine 322 in the human IgG3 CH2 domain is crucial for antibody dependent complement activation (Q59243312) (← links)
• Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis (Q59243333) (← links)
• Activation of complement by an IgG molecule without a genetic hinge (Q59243342) (← links)
• Structural motifs involved in human IgG antibody effector functions (Q61651725) (← links)
• A humanized monovalent CD3 antibody which can activate homologous complement (Q61651734) (← links)
• Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life. (Q64928870) (← links)
• Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies (Q89857555) (← links)